Healthcare today is undergoing a quiet transformation, one driven not by hospital expansions or new pharmaceuticals, but by ...

Rubrik (RBRK) is rated Hold: strong ARR growth, but SBC-driven cash flow, dilution risk, and unprofitability raise concerns.